It provided evidence of the association between PAI-1 −675 4G/5G polymorphism and asthma risk, supporting the hypothesis that the PAI-1 −675 4G/5G polymorphism may be a susceptibility marker for asthma. The gene discussed is SERPINE1; the disease is asthma.